Diet drug makers rally on FDA vote
December 08, 2010 at 14:04 PM EST
Diet drug developers Orexigen, Arena and Vivus are rallying on news that an FDA advisory panel is backing the approval of Orexigen’s diet pill Contrave.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.